Valley is aware of the nationwide supply disruption of IV fluid solution due to Hurricane Helene, and wants to reassure the community that steps have been taken to ensure the situation will have no negative impact on our patients and the community.
Heart failure (HF) affects approximately 5.7 million adults in the United States according to the Centers for Disease Control and Prevention. If not properly managed, HF can lead to frequent hospitalizations. A heart failure hospitalization should be viewed as a sentinel event. Five year survival after a heart failure hospitalization is only 20 percent, a prognosis that is worse than most cancer diagnoses. Importantly, if HF is properly managed by team of skilled heart failure clinicians, prognosis and quality of life can improve.
According to the American Heart Association (AHA), the most common symptoms of HF include:
It is important for patients to be knowledgeable about heart failure symptoms. Alerting your health care team to subtle changes in symptoms can prevent a heart failure hospitalization and allow you to live a full and productive life. Signs and symptoms to monitor are:
There are many effective treatments for patients with heart failure. Below are common medications used to help strengthen weakened hearts and/or manage symptoms of congestion.
In patients with weakened hearts, implantable cardioverter-defibrillators (ICD), cardiac resynchronization therapy (CRT), left ventricular assist devices (LVAD), or heart transplantation may be explored. Percutaneous coronary intervention (PCI) (also referred to as angioplasty) or coronary artery bypass may be recommended for heart failure caused by coronary artery disease. For heart failure caused by valvular disease, valve replacement may be recommended.
To help prevent future hospitalizations, the National Heart, Lung and Blood Institute recommends:
The Valley Hospital Heart Failure Program treats and manages heart failure patients in an outpatient setting on the hospital’s main campus. The program, which is certified by The Joint Commission, takes a multidisciplinary approach to care. The team works closely with pharmacy and palliative care staff. There is a strong focus on patient training and education to empower patients to effectively manage their conditions. For more information on the program, please call 201-447-8018.